Home › Compare › GMXDF vs JNJ

GMXDF vs JNJ: Dividend Comparison 2026

GMXDF yields 11627.91% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMXDF wins by $244118315279098048.00M in total portfolio value
10 years
GMXDF
GMXDF
● Live price
11627.91%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$244118315279098048.00M
Annual income
$240,057,148,074,998,000,000,000.00
Full GMXDF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GMXDF vs JNJ

📍 GMXDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMXDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMXDF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GMXDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMXDF
Annual income on $10K today (after 15% tax)
$988,372.09/yr
After 10yr DRIP, annual income (after tax)
$204,048,575,863,748,320,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GMXDF beats the other by $204,048,575,863,748,320,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMXDF + JNJ for your $10,000?

GMXDF: 50%JNJ: 50%
100% JNJ50/50100% GMXDF
Portfolio after 10yr
$122059157639549024.00M
Annual income
$120,028,574,037,499,000,000,000.00/yr
Blended yield
98.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GMXDF
No analyst data
Altman Z
1.2
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMXDF buys
0
JNJ buys
0
No recent congressional trades found for GMXDF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMXDFJNJ
Forward yield11627.91% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$244118315279098048.00M ✓$20.0K
Annual income after 10y$240,057,148,074,998,000,000,000.00 ✓$827.78
Total dividends collected$243848713425388256.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GMXDF vs JNJ ($10,000, DRIP)

YearGMXDF PortfolioGMXDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,173,491$1,162,790.70$10,676$355.77+$1.16M → GMXDF
2$128,781,249$127,525,613.74$11,407$389.39+$128.77M → GMXDF
3$13,217,159,909$13,079,363,973.17$12,198$426.53+$13217.15M → GMXDF
4$1,268,693,474,190$1,254,551,113,086.85$13,056$467.62+$1268693.46M → GMXDF
5$113,901,708,647,080$112,544,206,629,696.95$13,987$513.12+$113901708.63M → GMXDF
6$9,564,938,093,943,486$9,443,063,265,691,110.00$14,998$563.56+$9564938093.93M → GMXDF
7$751,341,707,037,911,900$741,107,223,277,392,400.00$16,098$619.52+$751341707037.90M → GMXDF
8$55,210,662,850,366,330,000$54,406,727,223,835,760,000.00$17,295$681.69+$55210662850366.32M → GMXDF
9$3,795,483,368,317,790,000,000$3,736,407,959,067,898,700,000.00$18,599$750.82+$3795483368317790.00M → GMXDF
10$244,118,315,279,098,030,000,000$240,057,148,074,998,000,000,000.00$20,022$827.78+$244118315279098048.00M → GMXDF

GMXDF vs JNJ: Complete Analysis 2026

GMXDF — Stock

Grupo Mexicano de Desarrollo, S.A.B. develops and operates infrastructure projects in Mexico. The company develops and operates port, maritime, and inland terminals; hydraulic infrastructure systems for potable water supply and wastewater treatment; private toll roads, and public highways and roads; and tourist destinations, including marinas, residential developments, and hotels. It also produces structural steel; and offers engineering, procurement, and construction services in various industries. In addition, the company is involved in the energy sector projects, including renewable power generation and hydrocarbon storage activities. The company was founded in 1942 and is based in Mexico City, Mexico.

Full GMXDF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GMXDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMXDF vs SCHDGMXDF vs JEPIGMXDF vs OGMXDF vs KOGMXDF vs MAINGMXDF vs ABBVGMXDF vs MRKGMXDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.